Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Reserpine: Alone and As an Adjunct to Psychotherapy in the Treatment of Schizophrenia

Reserpine: Alone and As an Adjunct to Psychotherapy in the Treatment of Schizophrenia Abstract This paper is a report on a controlled study which extended over a period of eight months using the drug reserpine. Reserpine (Serpasil) offers many of the advantages of present pharmaceutical techniques without incurring many of the liabilities. It acts as a tranquilizer, quieting the patients but leaving their sensorium clear and clouding consciousness but little. Its primary use appears to be in quieting agitated and disturbing patients. We feel that it in no way affects the psychosis itself. The most exacting test of the effectiveness of this drug would be in using it with chronic, severely disturbed and agitated patients who had failed to improve under the usual regime of treatment, such as insulin coma therapy and electroconvulsive therapy. This would be not only a definitive measure of drug effectiveness but also the most reliable measure. Any improvement shown could then definitely be considered a result of the treatment, References 1. References 1 and 2. 2. Cowden, R. C.; Deabler, H. L., and Feamster, J. H.: Prognostic Value of the Bender-Gestalt, H-T-P, TAT, and Sentence Completion Test , J. Clin. Psychol. 11:271-275, 1955.Crossref 3. Cowden, R. C.; Zax, M.; Hague, J. R., and Finney, R. C.: Chlorpromazine—Alone and as an Adjunct to Group Psychotherapy in the Treatment of Psychiatric Patients , Am. J. Psychiat. , to be published. 4. Gellhorn, E.: Physiological Foundations of Neurology and Psychiatry , Minneapolis, University of Minnesota Press, 1953. 5. Plummer, A. J.; Earl, A.; Schneider, J. A.; Tropold, J., and Barrett, W.: Pharmacology of Rauwolfia Alkaloids, Including Reserpine , Ann. New York Acad. Sc. 59:8-21, 1954.Crossref 6. Schneider, J. A.; Plummer, A. J.; Earl, A. E., and Gaunt, R.: Neuropharmacological Aspects of Reserpine , Ann. New York Acad. Sc. 61:17-26, 1955.Crossref http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png A.M.A. Archives of Neurology & Psychiatry American Medical Association

Reserpine: Alone and As an Adjunct to Psychotherapy in the Treatment of Schizophrenia

Loading next page...
 
/lp/american-medical-association/reserpine-alone-and-as-an-adjunct-to-psychotherapy-in-the-treatment-of-ojrDgqIVhg
Publisher
American Medical Association
Copyright
Copyright © 1955 American Medical Association. All Rights Reserved.
ISSN
0096-6886
DOI
10.1001/archneurpsyc.1955.02330170052009
Publisher site
See Article on Publisher Site

Abstract

Abstract This paper is a report on a controlled study which extended over a period of eight months using the drug reserpine. Reserpine (Serpasil) offers many of the advantages of present pharmaceutical techniques without incurring many of the liabilities. It acts as a tranquilizer, quieting the patients but leaving their sensorium clear and clouding consciousness but little. Its primary use appears to be in quieting agitated and disturbing patients. We feel that it in no way affects the psychosis itself. The most exacting test of the effectiveness of this drug would be in using it with chronic, severely disturbed and agitated patients who had failed to improve under the usual regime of treatment, such as insulin coma therapy and electroconvulsive therapy. This would be not only a definitive measure of drug effectiveness but also the most reliable measure. Any improvement shown could then definitely be considered a result of the treatment, References 1. References 1 and 2. 2. Cowden, R. C.; Deabler, H. L., and Feamster, J. H.: Prognostic Value of the Bender-Gestalt, H-T-P, TAT, and Sentence Completion Test , J. Clin. Psychol. 11:271-275, 1955.Crossref 3. Cowden, R. C.; Zax, M.; Hague, J. R., and Finney, R. C.: Chlorpromazine—Alone and as an Adjunct to Group Psychotherapy in the Treatment of Psychiatric Patients , Am. J. Psychiat. , to be published. 4. Gellhorn, E.: Physiological Foundations of Neurology and Psychiatry , Minneapolis, University of Minnesota Press, 1953. 5. Plummer, A. J.; Earl, A.; Schneider, J. A.; Tropold, J., and Barrett, W.: Pharmacology of Rauwolfia Alkaloids, Including Reserpine , Ann. New York Acad. Sc. 59:8-21, 1954.Crossref 6. Schneider, J. A.; Plummer, A. J.; Earl, A. E., and Gaunt, R.: Neuropharmacological Aspects of Reserpine , Ann. New York Acad. Sc. 61:17-26, 1955.Crossref

Journal

A.M.A. Archives of Neurology & PsychiatryAmerican Medical Association

Published: Nov 1, 1955

References